Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$2.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 14 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 50 most recent Form 4 transactions.
| Aug 14 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 14 | STOK | Stoke Therapeutics, Inc. | MEXER | 6,000 | — | — | +33.2% | Open the original filing on SEC.gov |
| Jun 16 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 1,457 | $29.95 | $43.6K | -7.5% | Open the original filing on SEC.gov |
| Mar 20 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 601 | $34.41 | $20.7K | -3.0% | Open the original filing on SEC.gov |
| Mar 20 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 8,692 | $33.64 | $292.4K | -30.1% | Open the original filing on SEC.gov |
| Mar 18 | STOK | Stoke Therapeutics, Inc. | SSELL | 72 | $32.85 | $2.4K | -0.3% | Open the original filing on SEC.gov |
| Mar 18 | STOK | Stoke Therapeutics, Inc. | SSELL | 334 | $31.79 | $10.6K | -1.1% | Open the original filing on SEC.gov |
| Mar 18 | STOK | Stoke Therapeutics, Inc. | SSELL | 4,222 | $31.28 | $132.1K | -12.6% | Open the original filing on SEC.gov |
| Mar 17 | STOK | Stoke Therapeutics, Inc. | SSELL | 1,791 | $33.38 | $59.8K | -5.1% | Open the original filing on SEC.gov |
| Mar 17 | STOK | Stoke Therapeutics, Inc. | SSELL | 2,476 | $32.74 | $81.1K | -6.6% | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 7,475 | — | — | — | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER | 12,000 | — | — | +46.6% | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER | 6,000 | — | — | +30.4% | Open the original filing on SEC.gov |
| Mar 15 | STOK | Stoke Therapeutics, Inc. | MEXER | 7,475 | — | — | +61.0% | Open the original filing on SEC.gov |
| Feb 17 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 35,000 | — | — | — | Open the original filing on SEC.gov |
| Feb 17 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 53,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 8, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 2,678 | $32.61 | $87.3K | -18.5% | Open the original filing on SEC.gov |
| Dec 8, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 1,300 | $31.60 | $41.1K | -8.2% | Open the original filing on SEC.gov |
| Dec 5, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 2,344 | $31.76 | $74.4K | -12.9% | Open the original filing on SEC.gov |
| Dec 5, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 5,437 | $31.08 | $169K | -23.1% | Open the original filing on SEC.gov |
| Dec 5, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 1,004 | $31.33 | $31.5K | -4.1% | Open the original filing on SEC.gov |
| Dec 4, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 194 | $31.32 | $6.1K | -0.8% | Open the original filing on SEC.gov |
| Dec 4, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 824 | $30.76 | $25.3K | -3.2% | Open the original filing on SEC.gov |
| Dec 3, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL | 1,394 | $30.85 | $43K | -6.6% | Open the original filing on SEC.gov |
| Dec 3, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL | 898 | $30.34 | $27.2K | -4.1% | Open the original filing on SEC.gov |
| Dec 3, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Dec 3, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷ | 6,000 | — | — | +30.6% | Open the original filing on SEC.gov |
| Dec 2, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL | 868 | $30.14 | $26.2K | -3.8% | Open the original filing on SEC.gov |
| Dec 2, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL | 1,416 | $29.56 | $41.9K | -5.9% | Open the original filing on SEC.gov |
| Dec 1, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 12,357 | — | — | — | Open the original filing on SEC.gov |
| Dec 1, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER | 12,357 | — | — | +104.5% | Open the original filing on SEC.gov |
| Oct 3, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷◆ | 10,000 | — | — | — | Open the original filing on SEC.gov |
| Oct 3, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 10,000 | $25.07 | $250.7K | -45.8% | Open the original filing on SEC.gov |
| Oct 3, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷ | 10,000 | $9.15 | $91.5K | +84.5% | Open the original filing on SEC.gov |
| Sep 3, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 6,345 | $20.07 | $127.3K | -34.9% | Open the original filing on SEC.gov |
| Sep 2, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷◆ | 9,150 | — | — | — | Open the original filing on SEC.gov |
| Sep 2, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 14,922 | $20.14 | $300.5K | -45.1% | Open the original filing on SEC.gov |
| Sep 2, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷ | 9,150 | $7.07 | $64.7K | +38.2% | Open the original filing on SEC.gov |
| Aug 29, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷◆ | 850 | — | — | — | Open the original filing on SEC.gov |
| Aug 29, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 850 | $20.00 | $17K | -3.4% | Open the original filing on SEC.gov |
| Aug 29, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◷ | 850 | $7.07 | $6K | +3.5% | Open the original filing on SEC.gov |
| Aug 18, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL | 1,683 | $18.24 | $30.7K | -6.6% | Open the original filing on SEC.gov |
| Aug 14, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER◆ | 6,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | STOK | Stoke Therapeutics, Inc. | AGRANT◆ | 12,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 14, 2025 | STOK | Stoke Therapeutics, Inc. | MEXER | 6,000 | — | — | +30.6% | Open the original filing on SEC.gov |
| Aug 13, 2025 | STOK | Stoke Therapeutics, Inc. | SSELL◷ | 13,712 | $15.00 | $205.7K | -41.1% | Open the original filing on SEC.gov |